Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheridan Henness

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Pharmacological interventions in the prevention of type 2 diabetesSheridan Henness
Current Opinion in Oncology|April 9, 2008
Management of Merkel tumours: an evidence-based reviewSheridan Henness, Pierre Vereecken
Current Opinion in Rheumatology|October 6, 2007
Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based reviewSheridan Henness, Fredrick M Wigley
Drugs|May 19, 2006
GadofosvesetSheridan Henness, Gillian M Keating
Drugs|November 15, 2006
VildagliptinSheridan Henness, Susan J Keam
Drugs|September 8, 2006
Orlistat: a review of its use in the management of obesitySheridan Henness, Caroline M Perry
Drugs|November 20, 2013
Modified-release prednisone: in patients with rheumatoid arthritisSheridan Henness, Lily P H Yang
Drugs & Aging|June 19, 2007
Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertensionSheridan Henness, Tracy Swainston Harrison, Gillian M Keating
Drugs|November 23, 2006
RimonabantSheridan Henness, Dean M Robinson, Katherine A Lyseng-Williamson
Nitric Oxide : Biology and Chemistry|August 5, 2003
Gypenosides derived from Gynostemma pentaphyllum suppress NO synthesis in murine macrophages by inhibiting iNOS enzymatic activity and attenuating NF-kappaB-mediated iNOS protein expressionFugen Aktan, Sheridan Henness, Basil D Roufogalis, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Pharmacological interventions in the prevention of type 2 diabetesSheridan Henness
Current Opinion in Oncology|April 9, 2008
Management of Merkel tumours: an evidence-based reviewSheridan Henness, Pierre Vereecken
Current Opinion in Rheumatology|October 6, 2007
Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based reviewSheridan Henness, Fredrick M Wigley
Drugs|May 19, 2006
GadofosvesetSheridan Henness, Gillian M Keating
Drugs|November 15, 2006
VildagliptinSheridan Henness, Susan J Keam
Drugs|September 8, 2006
Orlistat: a review of its use in the management of obesitySheridan Henness, Caroline M Perry
Drugs|November 20, 2013
Modified-release prednisone: in patients with rheumatoid arthritisSheridan Henness, Lily P H Yang
Drugs & Aging|June 19, 2007
Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertensionSheridan Henness, Tracy Swainston Harrison, Gillian M Keating
Drugs|November 23, 2006
RimonabantSheridan Henness, Dean M Robinson, Katherine A Lyseng-Williamson
Nitric Oxide : Biology and Chemistry|August 5, 2003
Gypenosides derived from Gynostemma pentaphyllum suppress NO synthesis in murine macrophages by inhibiting iNOS enzymatic activity and attenuating NF-kappaB-mediated iNOS protein expressionFugen Aktan, Sheridan Henness, Basil D Roufogalis, et al.
Pageof 2